Akèy › Myelofibroz › Florid › Miami
Etid klinik pou Myelofibroz nan Miami, FL
10 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Ap rekriteFaz 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Ap rekriteFaz 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Ap rekriteFaz 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Ap rekriteFaz 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Ap rekriteFaz 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Ap rekriteFaz 3
- University of Miami, Miami
Etid Myelofibroz nan lòt vil
- Houston, TX19 etid
- New York City, NY18 etid
- Boston, MA12 etid
- Durham, NC12 etid
- Columbus, OH11 etid
- Seattle, WA11 etid
- Salt Lake City, UT10 etid
- Atlanta, GA9 etid
- Tampa, FL9 etid
- Nashville, TN9 etid
- Cleveland, OH9 etid
- Baldwin Park, CA9 etid
Lòt etid nan Miami
- Kansè nan tete42 etid
- Kansè (tout kalite)36 etid
- Kansè Poumon ki pa ti selil31 etid
- Kansè pwostat27 etid
- Obèsite27 etid
- Leksemi mieloïd egi24 etid
- Kansè Metastatik24 etid
- Kansè ovè23 etid
- Sipwa23 etid
- Myelom Miltip21 etid
- Kolit Ulseratif21 etid
- Maladi Alzheimer20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.